Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Related Citations for PubMed (Select 16682719)

1.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, Demetri G, Desch CE, Pizzo PA, Schiffer CA, Schwartzberg L, Somerfield MR, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Wolff AC.

J Clin Oncol. 2006 Jul 1;24(19):3187-205. Epub 2006 May 8.

2.
3.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C; European Organisation for Research and Treatment of Cancer.

Eur J Cancer. 2011 Jan;47(1):8-32. doi: 10.1016/j.ejca.2010.10.013. Epub 2010 Nov 20.

PMID:
21095116
5.

Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.

Renner P, Milazzo S, Liu JP, Zwahlen M, Birkmann J, Horneber M.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD007913. doi: 10.1002/14651858.CD007913.pub2. Review.

PMID:
23076939
6.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.

Gerlier L, Lamotte M, Awada A, Bosly A, Bries G, Cocquyt V, Focan C, Henry S, Lalami Y, Machiels JP, Mebis J, Straetmans N, Verhoeven D, Somers L.

BMC Cancer. 2010 Nov 23;10:642. doi: 10.1186/1471-2407-10-642.

7.

Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines.

Heuser M, Ganser A, Bokemeyer C; American Society of Clinical Oncology; National Comprehensive Cancer Network; European Organization for Research and Treatment of Cancer.

Semin Hematol. 2007 Jul;44(3):148-56. Review.

PMID:
17631179
8.

Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.

Lugtenburg P, Silvestre AS, Rossi FG, Noens L, Krall W, Bendall K, Szabo Z, Jaeger U.

Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):297-305. doi: 10.1016/j.clml.2012.06.004.

PMID:
23040435
9.

Clinical practice guidelines for the use of colony-stimulating factors in cancer treatment: Implications for oncology nurses.

Kearney N, Friese C.

Eur J Oncol Nurs. 2008 Feb;12(1):14-25. doi: 10.1016/j.ejon.2007.10.001. Review.

PMID:
18291720
10.

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.

Aapro MS, Cameron DA, Pettengell R, Bohlius J, Crawford J, Ellis M, Kearney N, Lyman GH, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C; European Organisation for Research and Treatment of Cancer (EORTC) Granulocyte Colony-Stimulating Factor (G-CSF) Guidelines Working Party.

Eur J Cancer. 2006 Oct;42(15):2433-53. Epub 2006 Jun 5. Review.

PMID:
16750358
11.

Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?

Aapro M, Crawford J, Kamioner D.

Support Care Cancer. 2010 May;18(5):529-41. doi: 10.1007/s00520-010-0816-y. Epub 2010 Feb 27.

12.

EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer.

Repetto L, Biganzoli L, Koehne CH, Luebbe AS, Soubeyran P, Tjan-Heijnen VC, Aapro MS.

Eur J Cancer. 2003 Nov;39(16):2264-72. Review.

PMID:
14556916
13.

Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy.

Herbst C, Naumann F, Kruse EB, Monsef I, Bohlius J, Schulz H, Engert A.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007107. doi: 10.1002/14651858.CD007107.pub2. Review.

PMID:
19160320
14.

Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy.

Chan A, Fu WH, Shih V, Coyuco JC, Tan SH, Ng R.

Support Care Cancer. 2011 Apr;19(4):497-504. doi: 10.1007/s00520-010-0843-8. Epub 2010 Mar 17.

PMID:
20232087
15.

Evidence-based use of colony-stimulating factors in elderly cancer patients.

Lyman GH, Kuderer N, Agboola O, Balducci L.

Cancer Control. 2003 Nov-Dec;10(6):487-99. Review.

17.

Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care.

Pettengell R, Aapro M, Brusamolino E, Caballero D, Coiffier B, Pfreundschuh M, Trneny M, Walewski J.

Clin Drug Investig. 2009;29(8):491-513. doi: 10.2165/00044011-200929080-00001. Review.

PMID:
19591512
18.

Colony-stimulating factors as an adjunct to chemotherapy in small cell lung cancer.

Urban T, Schuller MP, Lebeau B.

Eur Respir J. 1996 Mar;9(3):596-602. Review.

19.

Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients.

Carrato A, Paz-Ares Rodríguez L, Rodríguez Lescure A, Casas Fernández de Tejerina AM, Díaz Rubio García E, Pérez Segura P, Constenla Figueiras M, García Carbonero R, Gómez Codina J, Lluch Hernández A, Maroto Rey JP, Martín Jiménez M, Mayordomo Cámara JI, Moreno Nogueira JA, Rueda Domínguez A; Spanish Society of Medical Oncology (SEOM).

Clin Transl Oncol. 2009 Jul;11(7):446-54.

PMID:
19574202
20.

Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology.

Bennett CL, Smith TJ, Weeks JC, Bredt AB, Feinglass J, Fetting JH, Hillner BE, Somerfield MR, Winn RJ.

J Clin Oncol. 1996 Sep;14(9):2511-20.

PMID:
8823330
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk